ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial
Nature Medicine
◽
10.1038/s41591-021-01569-2
◽
2021
◽
Author(s):
Evdoxia Kyriazopoulou
◽
Garyfallia Poulakou
◽
Haralampos Milionis
◽
Simeon Metallidis
◽
Georgios Adamis
◽
...
Keyword(s):
Early Treatment
◽
Plasma Levels
◽
Phase 3
◽
Double Blind
◽
Randomized Controlled
Download Full-text
Related Documents
Cited By
References
Blonanserin versus haloperidol in Japanese patients with schizophrenia: A phase 3, 8‐week, double‐blind, multicenter, randomized controlled study
Neuropsychopharmacology Reports
◽
10.1002/npr2.12057
◽
2019
◽
Vol 39
(3)
◽
pp. 173-182
◽
Cited By ~ 3
Author(s):
Philip D. Harvey
◽
Hiroshi Nakamura
◽
Mitsukuni Murasaki
Keyword(s):
Japanese Patients
◽
Randomized Controlled Study
◽
Controlled Study
◽
Phase 3
◽
Double Blind
◽
Randomized Controlled
Download Full-text
Early treatment of Borderline Pulmonary Arterial Hypertension associated with Systemic Sclerosis: a randomized, controlled, double-blind, parallel group, proof-of-concept study
10.1055/s-0039-1678198
◽
2019
◽
Author(s):
Z Pan
◽
N Benjamin
◽
C Eichstaedt
◽
N Blank
◽
HM Lorenz
◽
...
Keyword(s):
Systemic Sclerosis
◽
Pulmonary Arterial Hypertension
◽
Arterial Hypertension
◽
Early Treatment
◽
Proof Of Concept
◽
Double Blind
◽
Concept Study
◽
Randomized Controlled
◽
Parallel Group
◽
Pulmonary Arterial
Download Full-text
Denosumab Versus Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Randomized Controlled Phase 3 Study—Asian Subgroup Analysis
Advances in Therapy
◽
10.1007/s12325-020-01395-x
◽
2020
◽
Vol 37
(7)
◽
pp. 3404-3416
Author(s):
Shang-Yi Huang
◽
Sung-Soo Yoon
◽
Kazuyuki Shimizu
◽
Wee Joo Chng
◽
Cheng-Shyong Chang
◽
...
Keyword(s):
Multiple Myeloma
◽
Zoledronic Acid
◽
Bone Disease
◽
Subgroup Analysis
◽
Newly Diagnosed
◽
Disease Treatment
◽
Phase 3
◽
Double Blind
◽
Randomized Controlled
Download Full-text
The Efficacy of the Kampo Formula Keishikashakuyakuto for Irritable Bowel Syndrome: A Phase 3, Multicenter, Double-Blind, Placebo- Controlled, Randomized Controlled Trial
Journal of Clinical Trials
◽
10.4172/2167-0870.1000345
◽
2018
◽
Vol 08
(02)
◽
Cited By ~ 1
Author(s):
Takuma Higurashi
◽
Akiko Fuyuki
◽
Hidenori Ohkubo
◽
Hiroshi Iida
◽
Masahiko Inamori
◽
...
Keyword(s):
Randomized Controlled Trial
◽
Irritable Bowel Syndrome
◽
Controlled Trial
◽
Phase 3
◽
Double Blind
◽
Double Blind Placebo
◽
Randomized Controlled
◽
Irritable Bowel
Download Full-text
High HBsAb titers consistent across 3 lots of the trivalent HepB vaccine, Sci-B-Vac: Results from the second pivotal phase 3 double-blind, randomized controlled trial designed to assess the lot-to-lot consistency of Sci-B-Vac in adults (CONSTANT)
Journal of Hepatology
◽
10.1016/s0168-8278(20)30675-9
◽
2020
◽
Vol 73
◽
pp. S70
Author(s):
Adam Finn
◽
Timo Vesikari
◽
Pierre Van Damme
◽
Isabel Leroux-Roels
◽
Geert Leroux-Roels
◽
...
Keyword(s):
Randomized Controlled Trial
◽
Controlled Trial
◽
Phase 3
◽
Pivotal Phase
◽
Double Blind
◽
Randomized Controlled
Download Full-text
A Randomized, Controlled, Double-Blind Phase 3 Study of Bevacizumab/Interferon- 2a vs Placebo/Interferon- 2a as First-line Therapy in Metastatic Renal Cell Carcinoma
MD Conference Express
◽
10.1177/155989770700700305
◽
2007
◽
Vol 7
(3)
◽
pp. 12-13
Author(s):
L. Alexander
◽
B. Escudier
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
First Line
◽
Phase 3
◽
Double Blind
◽
Randomized Controlled
◽
First Line Therapy
◽
Line Therapy
Download Full-text
Early treatment of borderline pulmonary arterial hypertension associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group, proof-of-concept study
10.1183/13993003.congress-2018.oa272
◽
2018
◽
Cited By ~ 1
Author(s):
Zixuan Pan
◽
Christina A. Eichstaedt
◽
Nicola Benjamin
◽
Norbert Blank
◽
Hanns-Martin Lorenz
◽
...
Keyword(s):
Systemic Sclerosis
◽
Pulmonary Arterial Hypertension
◽
Arterial Hypertension
◽
Early Treatment
◽
Proof Of Concept
◽
Double Blind
◽
Concept Study
◽
Randomized Controlled
◽
Parallel Group
◽
Pulmonary Arterial
Download Full-text
Erratum to: Chan RJ, Mann J, Tripcony L, et al. Natural Oil-Based Emulsion Containing Allantoin Versus Aqueous Cream for Managing Radiation-Induced Skin Reactions in Patients With Cancer: A Phase 3, Double-Blind, Randomized, Controlled Trial. Int J Radiat Oncol Biol Phys 2014 Aug 20 [Epub ahead of print]. http://dx.doi.org/10.1016/j.ijrobp.2014.06.034.
International Journal of Radiation Oncology*Biology*Physics
◽
10.1016/j.ijrobp.2014.09.005
◽
2014
◽
Vol 90
(5)
◽
pp. 1262
◽
Cited By ~ 1
Keyword(s):
Randomized Controlled Trial
◽
Radiat Oncol Biol Phys
◽
Controlled Trial
◽
Phase 3
◽
Double Blind
◽
Skin Reactions
◽
Patients With Cancer
◽
Randomized Controlled
◽
Natural Oil
◽
Radiation Induced
Download Full-text
Efficacy and Safety of Ceftazidime-Avibactam Plus Metronidazole Versus Meropenem in the Treatment of Complicated Intra-abdominal Infection: Results From a Randomized, Controlled, Double-Blind, Phase 3 Program
Clinical Infectious Diseases
◽
10.1093/cid/ciw133
◽
2016
◽
Vol 62
(11)
◽
pp. 1380-1389
◽
Cited By ~ 165
Author(s):
John E. Mazuski
◽
Leanne B. Gasink
◽
Jon Armstrong
◽
Helen Broadhurst
◽
Greg G. Stone
◽
...
Keyword(s):
Efficacy And Safety
◽
Phase 3
◽
Double Blind
◽
Abdominal Infection
◽
Randomized Controlled
◽
Intra Abdominal Infection
Download Full-text
Oral nicotinamide to reduce actinic cancer: A phase 3 double-blind randomized controlled trial.
Journal of Clinical Oncology
◽
10.1200/jco.2015.33.15_suppl.9000
◽
2015
◽
Vol 33
(15_suppl)
◽
pp. 9000-9000
Author(s):
Andrew James Martin
◽
Andrew Chen
◽
Bonita Choy
◽
Pablo Fernandez Penas
◽
Gary Halliday
◽
...
Keyword(s):
Randomized Controlled Trial
◽
Controlled Trial
◽
Phase 3
◽
Double Blind
◽
Randomized Controlled
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close